Bigul

Metropolis Healthcare Ltd - 542650 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyMetropolis Healthcare Ltd 2CIN NO.L73100MH2000PLC192798 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 79.17 4Highest Credit Rating during the previous FY AA- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Neha Shah Designation: Interim Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Rakesh Agarwal Designation: Chief Financial Officer EmailId: [email protected] Date: 19/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
19-04-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Compliance Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Pursuant to Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Compliance Certificate obtained by the Company from Mr. Janmejay Singh Rajput of M/s. Janmejay Singh Rajput & Associates, Company Secretaries for the financial year ended March 31, 2023.
13-04-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

This is to inform you that, with reference to the above-mentioned subject, the Nomination and Remuneration Committee of the Board of the Directors of the Company, via circular resolution dated April 13, 2023, have inter alia: Approved the allotment of 158 (One Hundred and Fifty-Eight Only) Equity shares of Rs.2/- (Rupees Two Only) each at an exercise price of Rs. 2/- (Rupees Two Only) each aggregating to Rs. 316 (Rupees Three Hundred and Sixteen Only) against the Restrictive Stock Units ('RSU') vested in and exercised by the employees of the Company under the MHL- Restrictive Stock Unit Plan, 2020. Further, the said shares shall rank pari passu in all respects with the existing Equity shares of the Company.
13-04-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We herewith enclose the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2023 received from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company.
10-04-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Sushil Shah & PACs
04-04-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Sushil Kanubhai Shah & PACs
04-04-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Metropolis Healthcare Limited Has Informed The Exchange Regarding ''Reconstitution Of Board Committees''.

This is to inform you that the Board of Directors of the Company at their Meeting held today i.e. Friday, March 31, 2023, have approved reconstitution of Audit Committee and Risk Management Committee of the Company with effect from April 01, 2023
01-04-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Duru Shah & PACs
31-03-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Duru Shah & PACs
31-03-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Closure of Trading Window

This is to inform you that pursuant to the Company's Code of Fair Disclosure of Unpublished Price Sensitive Information framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading window for dealing in securities of the Company by the Designated Persons of the Company and/or their immediate relatives will be closed with effect from April 01, 2023 and shall remain closed up to 48 (Forty-Eight) hours after the declaration of the Financial Results of the Company for the quarter and year ending March 31, 2023. The date of the Board Meeting for approval of Financial Results of the Company for the quarter and year ending March 31, 2023, shall be intimated in due course.
30-03-2023
Next Page
Close

Let's Open Free Demat Account